Literature DB >> 6684641

The use of cell fusion to analyse factors involved in tumour cell metastasis.

I A Ramshaw, S Carlsen, H C Wang, P Badenoch-Jones.   

Abstract

Cell fusion has been used to study some of the factors involved in the process of metastasis. Highly metastatic rat mammary adenocarcinoma cells were fused with various non-metastatic cells and the hybrid clones isolated. These were then tested for their metastatic potential either by injecting the cells intravenously and measuring lung colony formation or by injecting the cells subcutaneously and measuring their ability to form lymphatic metastases. With most hybrid clones tested, the metastatic potential was either inhibited or greatly suppressed; thus this phenotype is a recessive characteristic. We also monitored the hybrid cells' ability to produce plasminogen activator (PA) a serine proteinase thought to be involved in the formation of metastatic lung foci. Whilst the highly metastatic parent cells produced large quantities of PA, none could be detected in the non-metastatic lines. Although the hybrid clones produced little PA activity this could not be correlated with their decreased metastatic potential in that one clone, after extensive in vitro culture, reverted to a more metastatic line without a concomitant increase in PA activity. The suppressed PA activity may be due to the presence of an inhibitor that is spontaneously produced by the hybrid cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6684641     DOI: 10.1002/ijc.2910320414

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

Review 1.  Studies on rat mammary adenocarcinomas: a model for metastasis.

Authors:  I A Ramshaw; P Badenoch-Jones
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 2.  Adhesion molecules in lymphoma metastasis.

Authors:  E Roos
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

3.  Ectopic G-CSF expression in human melanoma lines marks a trans-dominant pathway of tumor progression.

Authors:  S Safarians; S P Rivera; M D Sternlicht; F Naeim; S H Barsky
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 4.  Quantitative genetic analysis of tumor progression.

Authors:  V Ling; A F Chambers; J F Harris; R P Hill
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 5.  Somatic cell fusion as a source of genetic rearrangement leading to metastatic variants.

Authors:  L Larizza; V Schirrmacher
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.

Authors:  T Ichikawa; Y Ichikawa; J T Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

7.  Melanoma x macrophage hybrids with enhanced metastatic potential.

Authors:  M Rachkovsky; S Sodi; A Chakraborty; Y Avissar; J Bolognia; J M McNiff; J Platt; D Bermudes; J Pawelek
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

8.  Frequent loss of heterozygosity at 8p22 chromosomal region in diffuse type of gastric cancer.

Authors:  Hedayat Allah Hosseini; Ali Ahani; Hamid Galehdari; Ali Mohammad Froughmand; Masoud Hosseini; Abdolrahim Masjedizadeh; Mohammad Reza Zali
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

9.  The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F.

Authors:  Hu Liu; Sheng-Long Ye; Jiong Yang; Zhao-You Tang; Yin-Kun Liu; Lun-Xiu Qin; Shuang-Jian Qiu; Rui-Xia Sun
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.